New Products In Brief
This article was originally published in The Gray Sheet
Recent approvals and launches include U-Systems’ somo-v automated breast ultrasound system for breast cancer screening, Covidien’s Viance and Enteer devices for chronic total occlusions, and Aptus Endosystems’ HeliFX aortic securement device.
You may also be interested in...
NGM’s Phase II data for FGF19 analog aldafermin shows ability to reduce liver fat and improve fibrosis, but also raises LDL-C. Company says it gets a broader effect this way and can manage the increased cholesterol.
CEO Richard Pops said the company will leverage in-house expertise for internally and externally developed neuroscience assets, but partner selectively to advance its IL-2 protein in cancer.